This is to inform the exchange that the meeting of the Board of Directors of the Company, pursuant to Regulation 29(2) & 33 of SEBI (LODR) Regulations, 2015, is scheduled to be held on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Colinz Laboratories' Board, at its meeting on 17th January 2026, approved the sale of its factory building, factory machinery, and factory land situated at Plot No 60, STICE, Sinnar-Shirdi Road, Sinnar, Nashik (Rs. 4 Crore per their reference) to M/s. Hilsun Foods And Drugs Private Limited for a total consideration of Rs. 4 Crore. The buyer is an unrelated third party, not part of the promoter or promoter group, and the transaction is at arm's length and outside any Scheme of Arrangement. Shareholders had already approved this sale through a Postal Ballot on 17th November 2025 under Regulation 37A of SEBI LODR. The sale is expected to be completed on or before 31st March 2026, with payment to be received in tranches as mutually agreed between the parties.
The company is divesting its physical manufacturing infrastructure at Sinnar, Nashik for Rs. 4 Crore. While this brings in cash, the long-term impact on shareholders depends on whether the company shifts operations elsewhere or winds down production. Investors should watch for further updates on business continuity and use of sale proceeds.